128 related articles for article (PubMed ID: 8529283)
1. Multi-chemothermoimmunotherapy for human colon adenocarcinoma in vitro.
Klostergaard J; Leroux ME; Hsu HA; Hsi BP; Siddik ZH; Danhauser LL; Tomasovi SP
Cancer Chemother Pharmacol; 1996; 37(3):235-41. PubMed ID: 8529283
[TBL] [Abstract][Full Text] [Related]
2. Enhanced sensitivity of human colon tumor cell lines in vitro in response to thermochemoimmunotherapy.
Klostergaard J; Leroux E; Siddik ZH; Khodadadian M; Tomasovic SP
Cancer Res; 1992 Oct; 52(19):5271-7. PubMed ID: 1394131
[TBL] [Abstract][Full Text] [Related]
3. Clonogenic survival studies of human colon tumor cell lines in vitro: combined hyperthermia, 5-fluorouracil/leucovorin, carboplatin and tumor necrosis factor.
Klostergaard J; Leroux ME; Tomasovic SP
Radiat Res; 1995 Jan; 141(1):44-8. PubMed ID: 7997513
[TBL] [Abstract][Full Text] [Related]
4. Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma.
Scheithauer W; Kornek GV; Marczell A; Karner J; Salem G; Greiner R; Burger D; Stöger F; Ritschel J; Kovats E; Vischer HM; Schneeweiss B; Depisch D
Br J Cancer; 1998 Apr; 77(8):1349-54. PubMed ID: 9579845
[TBL] [Abstract][Full Text] [Related]
5. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusion.
Arkenau HT; Rettig K; Porschen R
Int J Colorectal Dis; 2005 May; 20(3):258-61. PubMed ID: 15549327
[TBL] [Abstract][Full Text] [Related]
7. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma.
Lorenz M; Müller HH
J Clin Oncol; 2000 Jan; 18(2):243-54. PubMed ID: 10637236
[TBL] [Abstract][Full Text] [Related]
8. p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon carcinoma cell lines.
Petak I; Tillman DM; Houghton JA
Clin Cancer Res; 2000 Nov; 6(11):4432-41. PubMed ID: 11106264
[TBL] [Abstract][Full Text] [Related]
9. Alternating bolus and continuous infusion 5-fluorouracil: a strategy to overcome resistance to this fluoropyrimidine in advanced colorectal cancer patients.
Guglielmi A; Aschele C; Grossi F; Tixi L; Sobrero A
Cytotechnology; 1996; 19(3):215-9. PubMed ID: 8862009
[TBL] [Abstract][Full Text] [Related]
10. Fluorouracil plus leucovorin as effective adjuvant chemotherapy in curatively resected stage III colon cancer: results of the trial adjCCA-01.
Porschen R; Bermann A; Löffler T; Haack G; Rettig K; Anger Y; Strohmeyer G;
J Clin Oncol; 2001 Mar; 19(6):1787-94. PubMed ID: 11251010
[TBL] [Abstract][Full Text] [Related]
11. Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.
Saltz LB; Niedzwiecki D; Hollis D; Goldberg RM; Hantel A; Thomas JP; Fields AL; Mayer RJ
J Clin Oncol; 2007 Aug; 25(23):3456-61. PubMed ID: 17687149
[TBL] [Abstract][Full Text] [Related]
12. In vivo potentiation of 5-fluorouracil by leucovorin in murine colon carcinoma.
Nadal JC; Van Groeningen CJ; Pinedo HM; Peters GJ
Biomed Pharmacother; 1988; 42(6):387-93. PubMed ID: 3064823
[TBL] [Abstract][Full Text] [Related]
13. [A case of colon cancer with local recurrence successfully treated by systemic and local intra-arterial chemotherapy using a combination of 5-fluorouracil, interferon-alpha 2A, leucovorin and carboplatin].
Takasaki S; Masumoto N; Tabata H; Nakamura M; Nakano S; Niho Y
Gan To Kagaku Ryoho; 1997 Jan; 24(1):109-13. PubMed ID: 9020955
[TBL] [Abstract][Full Text] [Related]
14. 5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice.
Saif MW; von Borstel R
Cancer Chemother Pharmacol; 2006 Jul; 58(1):136-42. PubMed ID: 16187114
[TBL] [Abstract][Full Text] [Related]
15. A phase II randomized study of combined infusional leucovorin sodium and 5- FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in patients with metastatic colorectal cancer.
Bleiberg H; Vandebroek A; Deleu I; Vergauwe P; Rezaei Kalantari H; D'Haens G; Paesmans M; Peeters M; Efira A; Humblet Y
Acta Gastroenterol Belg; 2012 Mar; 75(1):14-21. PubMed ID: 22567742
[TBL] [Abstract][Full Text] [Related]
16. Comparison between CoFactor and Leucovorin activity applied in combination with 5-fluorouracil against two human colon cancer cell lines.
Bjelogrlić SK; Srdić T; Radulović S
J BUON; 2007; 12(1):71-6. PubMed ID: 17436405
[TBL] [Abstract][Full Text] [Related]
17. Synergism and lack of cross-resistance between short-term and continuous exposure to fluorouracil in human colon adenocarcinoma cells.
Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Melioli GG; Rosso R; Bertino JR
J Natl Cancer Inst; 1993 Dec; 85(23):1937-44. PubMed ID: 8230285
[TBL] [Abstract][Full Text] [Related]
18. Enhanced antitumor activity of irofulven in combination with 5-fluorouracil and cisplatin in human colon and ovarian carcinoma cells.
Poindessous V; Koeppel F; Raymond E; Cvitkovic E; Waters SJ; Larsen AK
Int J Oncol; 2003 Nov; 23(5):1347-55. PubMed ID: 14532976
[TBL] [Abstract][Full Text] [Related]
19. [Combination chemotherapy with orally administered UFT and leucovorin (LV)].
Okabe H; Saito H; Oie S; Nakano K; Uchida J; Takechi T; Takeda S; Kawaguchi Y; Taguchi T
Gan To Kagaku Ryoho; 1991 Aug; 18(10):1645-50. PubMed ID: 1872623
[TBL] [Abstract][Full Text] [Related]
20. Oral uracil/ftorafur (UFT) plus leucovorin as first-line chemotherapy and salvage therapy with weekly high-dose 5-fluorouracil/leucovorin for the treatment of metastatic colorectal cancer.
Yang TS; Wang JY; Tang R; Hsu KC; Chen JS
Jpn J Clin Oncol; 2002 Sep; 32(9):352-7. PubMed ID: 12417601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
